U.S. Packaging Stock News

NasdaqGS:RELY
NasdaqGS:RELYDiversified Financial

Remitly Global CEO Shift Puts Profitability And Valuation In Focus

Remitly Global (NasdaqGS:RELY) has appointed Sebastian Gunningham as CEO, succeeding co founder Matt Oppenheimer. The leadership change coincides with the announcement of Remitly's first full year of GAAP profitability. The company also reported record quarterly financial results alongside the CEO transition. Remitly focuses on digital cross border remittances, offering migrant workers and their families app based money transfer services. The combination of a new CEO and confirmation of...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Reassessing Domino’s Pizza (DPZ) After A Year Of Share Price Weakness

For readers wondering whether Domino's Pizza at around US$382.99 represents a bargain or whether the easier gains may have already occurred, this article walks through what the current price might reflect about the business. The share price is around US$382.99 after a 0.3% decline over the last 7 days, a 4.3% decline over 30 days, a 9.9% decline year to date, and an 18.1% decline over the past year. The 3 year and 5 year returns sit at 14.7% and 11.9% respectively. Recent headlines around...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Assessing Apellis Pharmaceuticals (APLS) Valuation After Mixed Returns And High P/E Versus DCF Fair Value Estimate

Recent share performance and business snapshot Apellis Pharmaceuticals (APLS) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past year and a market reaction that contrasts with its more recent monthly performance. The share price is up about 11% over the past month and around 14% over the past 3 months, while the 1 year total return is a decline of roughly 22%, and the 3 year total return is a decline of about 66%. Year to date, the...
NYSE:SPH
NYSE:SPHGas Utilities

Assessing Suburban Propane Partners (SPH) Valuation After First Quarter Earnings Jump

Suburban Propane Partners (SPH) caught investor attention after reporting first quarter 2025 earnings, with net income of US$45.78 million compared to US$19.42 million a year earlier, on relatively stable revenue of about US$370 million. See our latest analysis for Suburban Propane Partners. The latest earnings release appears to sit alongside gradually improving sentiment, with a 30 day share price return of 5.52% and a 90 day gain of 8.35%. The 5 year total shareholder return of 96.45%...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Margin Surge To 25.5% Reinforces Bullish Profitability Narrative

Wingstop (WING) just posted its FY 2025 third quarter numbers, reporting revenue of US$175.7 million and basic EPS of US$1.02, while trailing twelve month EPS is US$6.15 on revenue of US$683.0 million. The company’s revenue has moved from US$162.5 million and EPS of US$0.88 in Q3 2024 to US$175.7 million and EPS of US$1.02 in Q3 2025. This sits alongside trailing net income of US$174.3 million, which contributes to the 25.5% net margin reported over the past year and highlights a results...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Net Margin Expansion Tests Bullish Long‑Term Profitability Narratives

Analog Devices (ADI) opened its new fiscal year with Q1 2026 results that sit on top of a clear ramp in recent quarters, with revenue moving from US$2,443.2 million in Q4 2024 to US$3,076.1 million in Q4 2025 and basic EPS stepping up from US$0.96 to US$1.60 over the same period. Over the trailing twelve months to Q4 2025, total revenue reached US$11.0 billion and basic EPS came in at US$4.59. This gives investors a fuller sense of earnings power coming into this latest print and sets the...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

A Look At Roivant Sciences (ROIV) Valuation After PHocus Trial Milestone And Weak Quarterly Earnings

Clinical and earnings updates shift focus for Roivant Sciences (ROIV) Roivant Sciences (ROIV) shares are in focus after the company reported a key clinical milestone for its pulmonary hypertension program and quarterly results that showed lower sales and a larger net loss compared with last year. See our latest analysis for Roivant Sciences. The clinical milestone and latest earnings are landing against a backdrop of strong momentum, with Roivant Sciences showing a 30 day share price return...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Assessing Match Group (MTCH) Valuation As User Metrics Weaken And Board Changes Continue

Board changes and weak user trends put Match Group in focus Match Group (MTCH) is back on investors’ radars after fresh boardroom changes and pressure on its core metrics, with payer counts, average revenue per user, and engagement all weakening over the last two years. See our latest analysis for Match Group. Despite the latest board reshuffle and weaker user metrics, Match Group’s recent share price returns have been slightly negative over most short timeframes, and its 1 year total...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly (FSLY) Is Up 102.3% After AI-Focused 2026 Outlook And Narrower 2025 Losses Has The Bull Case Changed?

Fastly, Inc. reported its fourth-quarter 2025 and full-year 2025 results on 11 February 2026, with quarterly sales rising to US$172.61 million from US$140.58 million and its annual net loss narrowing to US$121.68 million on revenue of US$624.02 million, compared with US$543.68 million a year earlier. Management paired this performance with 2026 revenue guidance of US$700 million to US$720 million and emphasized growing demand from AI-related traffic and security services as key drivers of...
NYSE:ALK
NYSE:ALKAirlines

How Strong Q4 Earnings and Broad Bonuses May Impact Alaska Air Group (ALK) Investors

Earlier this month, Alaska Air Group reported fourth-quarter 2025 results with adjusted EPS of US$0.43 versus analyst expectations of US$0.11, while Executive Vice President and Chief Commercial Officer Andrew R. Harrison sold about US$794,762 of stock after exercising restricted stock units. On February 15, 2026, the company also awarded nearly three weeks of performance-based bonus pay to more than 32,000 employees, underscoring management’s focus on operational execution, service...
NYSE:HII
NYSE:HIIAerospace & Defense

Huntington Ingalls Taps AI Welding As Investors Weigh Productivity And Valuation

Huntington Ingalls Industries (NYSE:HII) has signed a memorandum of understanding with Path Robotics to integrate AI-driven autonomous welding into shipbuilding operations. The agreement focuses on jointly developing physical AI-based welding systems for use across HII's shipyards. The collaboration aims to automate welding tasks, support the existing workforce, and increase throughput in naval ship production. For a company like Huntington Ingalls Industries, which builds complex naval...
NYSE:TROX
NYSE:TROXChemicals

Tronox Holdings (TROX) Is Down 7.8% After Wider 2025 Losses Despite Maintained Dividend - What's Changed

Tronox Holdings plc has released its fourth-quarter and full-year 2025 results, showing quarterly sales rising to US$730 million but a much larger net loss of US$176 million, and full-year sales slipping to US$2.90 billions alongside a significantly wider US$470 million loss. Despite these deeper losses, the board maintained a cash dividend of US$0.05 per share and confirmed a director’s decision not to seek re-election for time-commitment reasons rather than any disagreement with the...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch + Lomb (BLCO) Loss Narrows To US$28m As Margin Repair Narrative Gains Traction

Bausch + Lomb (NYSE:BLCO) has put out its latest FY 2025 numbers with Q3 revenue of US$1.3b and a basic EPS loss of US$0.08, as investors weigh how far the business has come toward closing the profitability gap. The company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.3b in Q3, while basic EPS losses over that stretch ranged from US$0.60 in Q1 to US$0.18 in Q2 and US$0.08 in Q3. This sets up the current update as a check-in on how quickly margins can repair from here. See...
NYSE:RBA
NYSE:RBACommercial Services

RB Global (RBA) Margin Slippage Tests Bullish Multi Year Earnings Growth Narrative

RB Global (RBA) has wrapped up FY 2025 with fourth quarter revenue of US$1.2 billion and basic EPS of US$0.53, alongside net income excluding extra items of US$99.1 million. This sets a clear marker for how the year finished. Across recent periods, the company has seen quarterly revenue range from US$981.8 million in Q3 2024 to US$1.2 billion in Q4 2025, while basic EPS moved between US$0.36 and US$0.56 over that span. This gives investors a concrete view of how the top and bottom lines have...
NYSE:VAC
NYSE:VACHospitality

Assessing Marriott Vacations Worldwide (VAC) Valuation After Recent Share Price Momentum

Why Marriott Vacations Worldwide (VAC) is Back on Investor Radars Recent trading in Marriott Vacations Worldwide (VAC) has drawn attention as investors reassess the timeshare and vacation ownership specialist, with the stock showing mixed returns across the past week, month, and past 3 months. See our latest analysis for Marriott Vacations Worldwide. At a share price of US$58.96, Marriott Vacations Worldwide has seen short term momentum pick up with a 2.38% 1 day and 6.16% 7 day share price...
NYSE:WMK
NYSE:WMKConsumer Retailing

Weis Markets (WMK) Valuation Check After Recent Share Price Momentum

Recent moves in Weis Markets stock Weis Markets (WMK) has caught investor attention after a steady run, with the share price at $72.70 and total return figures that differ sharply between the past month, past 3 months, and recent years. See our latest analysis for Weis Markets. At a share price of $72.70, Weis Markets has seen short term momentum, with a 30 day share price return of 5.38% and a 90 day share price return of 10.86%. The 1 year total shareholder return of 3.45% contrasts with a...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

A Look At InterDigital (IDCC) Valuation After New Global Patent Agreement With Sony

InterDigital (IDCC) is back in focus after signing a new global patent license agreement with Sony that covers cellular, WiFi, and video technologies across all Sony end user devices. See our latest analysis for InterDigital. The Sony agreement follows a busy few weeks for InterDigital, including fourth quarter results, fresh 2026 guidance, a buyback update, and the launch of the Haptic Excellence Center with Razer. Despite a 1 day share price return of 1.31% decline to US$361.61, the 30 day...
NYSE:DLB
NYSE:DLBSoftware

Is Dolby Laboratories (DLB) Pricing Reflect Its Potential After Multi Year Share Price Slump

If you are wondering whether Dolby Laboratories' current share price reflects its true worth, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$64.82, with returns of 3.7% over the last 30 days but a 20.7% decline over the past year and a 28.0% decline over five years, which may have changed how some investors view its risk and reward trade off. Recent coverage has focused on Dolby Laboratories' role in audio and visual technologies...
NYSE:NET
NYSE:NETIT

Is It Too Late To Consider Cloudflare (NET) After Its Strong Multi Year Share Price Run?

If you are wondering whether Cloudflare's share price still lines up with its underlying worth, this article will walk through what the current numbers say and where valuation checks seem to disagree with the story. At a recent close of US$191.44, Cloudflare's stock has returned 1.1% over the last week, 3.9% over the last month, a 2.3% decline year to date, and 19.2% over the past year, with a very large 3 year gain of 211.4% and a 5 year gain of 150.5%. Recent headlines around Cloudflare...
NYSE:HMN
NYSE:HMNInsurance

A Look At Horace Mann Educators (HMN) Valuation After Launch Of No Cost Horace Mann Club

Horace Mann Club launch puts educator relationships in focus Horace Mann Educators (HMN) has launched the Horace Mann Club, a no cost program offering educators nationwide benefits like wellness partnerships, financial tools, classroom resources, and professional development opportunities. This service expansion is directly aimed at deepening engagement with the company’s core customer base. This may matter for investors tracking how product ecosystems support retention and cross selling in...
NYSE:YOU
NYSE:YOUSoftware

Did Growing Institutional Attention to Clear Secure’s (YOU) Biometric Platform Quietly Recast Its Competitive Moat?

In recent days, Clear Secure has drawn heightened attention as a frequently searched stock, with analysts and institutional investors emphasizing its consistent outperformance versus earnings and revenue estimates despite an anticipated year-over-year decline in current-quarter EPS to $0.31. Portfolio recognition from Meridian Hedged Equity Fund and continued confidence from Telsey Advisory Group highlight Clear Secure’s positioning as an innovator in biometric identity verification and...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

Is GE HealthCare Technologies (GEHC) Pricing Reflect Its Post Spinoff Potential Today

If you are wondering whether GE HealthCare Technologies is fairly priced today, this article walks through what the current share price might be implying about its underlying value. The stock last closed at US$82.95, with returns of 4.7% over the past week, 1.5% over the past month, a small 0.2% gain year to date, and a 10.2% decline over the past year. These moves may have some investors reassessing the balance between upside potential and risk. Recent attention on GE HealthCare has focused...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet Group (TNET) Is Down 6.0% After Lower 2026 Outlook And Buyback Update – Has The Bull Case Changed?

In February 2026, TriNet Group reported fourth-quarter 2025 revenue of US$1,248 million with a net loss of US$1 million, and full-year 2025 revenue of US$5,010 million with net income of US$155 million, alongside new 2026 guidance and an update on its long-running share repurchase program. The company’s 2026 outlook, which points to lower total revenue of US$4,750 million to US$4,900 million and reduced diluted earnings per share of US$2.15 to US$3.05, raises fresh questions about how its...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

FDA Greenlights ENHANCE Heart Trial As TransMedics Valuation Draws Attention

TransMedics Group received full FDA approval for its Next-Generation OCS ENHANCE Heart trial Investigational Device Exemption. The trial is designed to assess the company’s Organ Care System Heart technology for prolonged heart perfusion versus current storage methods. This FDA decision marks a material development for NasdaqGM:TMDX and its organ transplant platform. TransMedics Group, trading on NasdaqGM:TMDX, now has a fresh regulatory green light that adds to its profile in the heart...